Clinical Trials · NCT05442450
Efficacy of Oral Semaglutide in Overweight or Obesity
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Asian Institute of Gastroenterology, India
- Enrollment
- 116
- Start date
- Jul 2022
- Locations
- 1 site, India
- Primary endpoint
- The proportion of patients achieving a reduction in body weight of 5% or more from baseline